De novo mutations in HNRNPU result in a neurodevelopmental syndrome

Exome sequencing in the context of developmental disorders is a useful technique, but variants found need to be interpreted in the context of detailed phenotypic information. Whole gene deletions and loss‐of‐function‐mutations in the HNRNPU gene have been associated with intellectual disability and...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of medical genetics. Part A Vol. 173; no. 11; pp. 3003 - 3012
Main Authors Yates, T. Michael, Vasudevan, Pradeep C., Chandler, Kate E., Donnelly, Deirdre E, Stark, Zornitza, Sadedin, Simon, Willoughby, Josh, Balasubramanian, Meena
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Exome sequencing in the context of developmental disorders is a useful technique, but variants found need to be interpreted in the context of detailed phenotypic information. Whole gene deletions and loss‐of‐function‐mutations in the HNRNPU gene have been associated with intellectual disability and seizures in some patients. However, a unifying syndromic phenotype has not been previously elucidated. Here, we report a total of seven patients (six patients identified through the Wellcome Trust Deciphering Developmental Disorders study, with one additional patient), who have heterozygous de novo mutations in HNRNPU. These were found via trio‐based exome sequencing. All but one of the mutations is predicted to cause loss‐of‐function. These patients have dysmorphic features in common, including prominent eyebrows, long palpebral fissures, overhanging columella, and thin upper lip. All patients have developmental delay and intellectual disability (ID), ranging from moderate to severe. Seizures are common from early childhood. These initially occur in the context of febrile episodes. This series demonstrates common phenotypic features, including emerging dysmorphism, associated with heterozygous HNRNPU mutations. This allows us to define a novel neurodevelopmental syndrome, with a likely mechanism of haploinsufficiency.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1552-4825
1552-4833
DOI:10.1002/ajmg.a.38492